Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CRMD
#2460
CorMedix Inc.
7.130
0
-1.79%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-1.79%
Aylık değişim
-8.24%
6 aylık değişim
-36.90%
Yıllık değişim
-36.90%
Önceki kapanış
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Hacim
99
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
CRMD
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
60.68 M
65.18 M
67.82 M
74.65 M
78.79 M
—
Valuation ratios
Enterprise value
454.99 M
487.32 M
351.51 M
760.37 M
867.82 M
2.47 B
Price to earnings ratio
-10.1
-27
24.64
15.79
5.56
19
Price to sales ratio
38.71
10.97
4.72
6.68
4.07
26.44
Price to cash flow ratio
-8.18
-9.42
-21.6
32.79
12.04
13.81
Price to book ratio
1.93
5.63
1.26
1.72
1.11
9.71
Enterprise value to EBITDA ratio
-8.97
-22.1
23.39
15.2
7.75
24.24
Profitability ratios
Return on assets %
-0.04
0.11
0.14
0.08
0.14
0.47
Return on equity %
-0.05
0.16
0.18
0.09
0.29
0.72
Return on invested capital %
-146.64
221.48
225.66
223.32
142.32
812.79
Gross margin %
94.01
96.23
95.91
95.31
89.26
376.73
Operating margin %
-28.7
41.45
51.5
49.18
49.24
191.37
EBITDA margin %
-27.57
42.04
51.91
49.72
56.45
200.13
Net margin %
-24.24
43.14
52.82
49.9
104.11
249.97
Liquidity ratios
Quick ratio
3.6
3.16
3.99
7.52
1.73
16.4
Current ratio
3.96
3.39
4.21
7.82
1.94
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.17
0.32
0.29
0.2
0.21
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.39
—
Long term debt to total equity ratio
—
—
—
—
0.79
—
Per share metrics
Operating cash flow per share
-0.23
-0.1
0.29
0.42
0.36
0.97
EBIT per share
-0.06
0.22
0.29
0.27
0.64
1.42
EBITDA per share
-0.05
0.22
0.29
0.27
0.68
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
0.78
0.88
1.12
2.65
0.65
5.3
Net current asset value per share
1.24
1.95
2.1
3.45
3.01
10.51
Tangible book value per share
0.97
1.41
1.64
3.04
-0.39
5.7
Working capital per share
0.93
1.37
1.6
3.01
1.46
7.44
Book value per share
1
1.44
1.67
3.07
4.34
10.51
Haberler
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
Citizens, CorMedix hissesi için Piyasa Performansı Üstü notunu yineledi
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
CorMedix hisseleri 75 milyon dolarlık geri alım planı açıklamasının ardından yükseldi
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix 75 milyon dolarlık hisse geri alım programını duyurdu
CorMedix announces $75 million share repurchase program